Illumina, Inc. - Common Stock (NQ:ILMN)

279.47 +8.43 (+3.11%)

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

10x Genomics Earnings: What To Look For From TXG

November 04, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

PacBio Earnings: What To Look For From PACB

November 03, 2025

Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be reporting results this Wednesday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Illumina (ILMN) Stock Trades Down, Here Is Why

November 03, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.4% in the afternoon session after its negative momentum continued as Barclays maintained its Underweight recommendation on the stock. The...

Via StockStory

Topics Artificial Intelligence Supply Chain

Earnings Scheduled For October 30, 2025 ↗

October 30, 2025

Via Benzinga

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗

November 03, 2025

Illumina's 23% post-earnings rally revives optimism across biotech ETFs as investors bet on a genomics rebound and ex-China growth in 2025.

Via Benzinga

Topics ETFs

Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗

November 02, 2025

Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results.

Via Benzinga

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗

October 31, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 31, 2025

Via Benzinga

Why Illumina (ILMN) Stock Is Up Today

October 31, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 22.4% in the afternoon session after it reported third-quarter 2025 financial results that beat profit expectations and raised its full-year...

Via StockStory

Topics Economy Government World Trade

DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗

October 31, 2025

Illumina shares rise after posting Q3 earnings and revenue above estimates, raising 2025 guidance and showing growth in clinical sequencing markets.

Via Benzinga

Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗

October 31, 2025

Via Benzinga

ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance

October 31, 2025

Genomics company Illumina (NASDAQ:ILMN) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share...

Via StockStory

Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally ↗

October 30, 2025

Illumina (ILMN) Q3 2025 earnings beat profit estimates, sending shares up 8.6%. Strong EPS of $1.34 on flat revenue impressed investors.

Via Chartmill

Topics Earnings

Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations

October 30, 2025

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $1.08 billion. Its non-GAAP profit of $1.34 per share was 14.7% above...

Via StockStory

What To Expect From Illumina’s (ILMN) Q3 Earnings

October 28, 2025

Genomics company Illumina (NASDAQ:ILMN) will be reporting results this Thursday after market close. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

Nvidia Rockets Towards $5 Trillion Valuation, Reshaping the Global Tech Landscape

October 28, 2025

As of October 2025, Nvidia (NASDAQ: NVDA) stands on the precipice of a historic $5 trillion market valuation, a testament to its unparalleled dominance in the artificial intelligence (AI) and...

Via MarketMinute

Topics Artificial Intelligence Economy

Looking Into Illumina Inc's Recent Short Interest ↗

October 22, 2025

Via Benzinga

Undervalued Opportunity: A Deep Dive into Illumina Inc (ILMN) ↗

October 22, 2025

Illumina (ILMN) presents a strong value investment case with attractive valuation, high profitability, and solid financial health, trading below industry peers.

Via Chartmill

JPMorgan, Alibaba, Columbia Banking System And A Health Care Stock On CNBC's 'Final Trades' ↗

October 21, 2025

JPMorgan is still Joshua Brown's favorite long-term investment, supported by strong Q3 earnings. Others also favor Illumina, Columbia & Alibaba.

Via Benzinga

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗

October 15, 2025

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.

Via Benzinga

Topics Artificial Intelligence

10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

1 Volatile Stock to Target This Week and 2 Facing Headwinds

October 07, 2025

Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor...

Via StockStory

Why Illumina (ILMN) Shares Are Falling Today

October 02, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) fell 3.3% in the afternoon session after an analyst at Barclays maintained a cautious "Underweight" rating on the company.

Via StockStory

Topics Artificial Intelligence

Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures

October 02, 2025

A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human...

Via MarketMinute

Topics Artificial Intelligence Derivatives

Assessing Illumina: Insights From 9 Financial Analysts ↗

October 02, 2025

Via Benzinga

Illumina's BioInsight Launch Sparks Optimism, Signals New Era for Genomic Data and AI

October 01, 2025

San Diego, CA – October 1, 2025 – Illumina, Inc. (NASDAQ: ILMN) saw its shares surge by 6.6% today following the announcement and immediate launch of its new business unit, BioInsight. This strategic...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism

October 01, 2025

Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Why Is Illumina (ILMN) Stock Rocketing Higher Today

October 01, 2025

Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the afternoon session after the company announced the launch of BioInsight, a new business unit designed to accelerate drug discovery...

Via StockStory

Topics Artificial Intelligence Lawsuit Whistleblower

Illumina Stock Surged 6% Today – Here’s Why ↗

October 01, 2025

The company announced that its new business will focus on developing data assets, software, and artificial intelligence to drive drug development.

Via Stocktwits

Topics Artificial Intelligence

Nvidia's AI Reign Ignites Stock Futures: A Trillion-Dollar Trajectory Reshapes the Market

September 30, 2025

San Francisco, CA – September 30, 2025 – Nvidia Corporation (NASDAQ: NVDA) continues its unprecedented ascent, cementing its position as the undisputed titan of the artificial intelligence (AI) era. As...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

< Previous 1 2 3 4 5 6 7 8 9

...

40 41 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.